Cannabis Science and Technology® magazine is seeking contributed manuscripts for our peer-review process and regular feature articles for upcoming 2024/2025 issues.
Manuscript scope and format
Cannabis Science and Technology® magazine is seeking contributed manuscripts for our peer-review process as well as regular features in our upcoming 2024/2025 issues. We welcome manuscripts that describe analytical methods for product quality control (including sample preparation techniques); the development of standard (consensus) methods; proper laboratory techniques and laboratory best practices; laboratory accreditation, proficiency testing, and inter-laboratory comparison testing; equipment and technology for testing and processing; regulatory issues; current good manufacturing practices (cGMPs); research on cannabinoids and terpenes; extraction methods, best practices, and troubleshooting; as well as cultivation techniques, tips and tricks, and troubleshooting.
Peer-Review Process
Articles that are submitted for peer-review will be sent to members of our editorial advisory board through a double-blinded process. Reviewers will provide comments related to the quality of the work and propose suggestions for areas of improvement. The authors will then receive those comments and be given additional time to consider the comments and make any necessary adjustments to their papers. We urge authors to submit a proposal to the editor before completing a manuscript. The following types of articles are suitable for peer-review:
Read our editorial information for more on manuscript formatting and preparation.
For more information, please contact editor Madeline Colli.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Is Cannabis a Solution to the Opioid Crisis?
January 23rd 2025In this research overview, Ruth Fisher, PhD, explores how cannabis has shown promise in helping individuals reduce opioid use, potentially decreasing overdose deaths. Though its impact on chronic pain and opioid reduction remains evident, limitations exist and flaws in methodologies in ecological studies complicate conclusions.